Rosacea — SCE Dermatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Subtype 1 — Erythematotelangiectatic rosacea
Erythematotelangiectatic rosacea (subtype 1) is characterised by flushing (transient erythema), persistent centrofacial erythema, and telangiectasia without inflammatory papules or pustules. Triggers include alcohol, spicy food, temperature extremes, UV exposure, and emotional stress. Treatment focuses on trigger avoidance, sun protection, topical Brimonidine gel (alpha-2 agonist that reduces erythema via vasoconstriction), and pulsed dye laser or IPL for telangiectasia. Subtype 2 (papulopustular) requires anti-inflammatory treatment with topical Metronidazole/Ivermectin or oral tetracyclines.
Reference: BAD 2021 Rosacea Guidelines; NICE CKS